Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2000 3
2001 2
2002 1
2003 5
2004 2
2005 2
2015 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes.
Kahn SE. Kahn SE. Diabetologia. 2003 Jan;46(1):3-19. doi: 10.1007/s00125-002-1009-0. Epub 2003 Jan 11. Diabetologia. 2003. PMID: 12637977 Review.
Islet amyloid: a critical entity in the pathogenesis of type 2 diabetes.
Hull RL, Westermark GT, Westermark P, Kahn SE. Hull RL, et al. J Clin Endocrinol Metab. 2004 Aug;89(8):3629-43. doi: 10.1210/jc.2004-0405. J Clin Endocrinol Metab. 2004. PMID: 15292279 Review.
Clinical review 135: The importance of beta-cell failure in the development and progression of type 2 diabetes.
Kahn SE. Kahn SE. J Clin Endocrinol Metab. 2001 Sep;86(9):4047-58. doi: 10.1210/jcem.86.9.7713. J Clin Endocrinol Metab. 2001. PMID: 11549624 Review. No abstract available.
Islet amyloid: a long-recognized but underappreciated pathological feature of type 2 diabetes.
Kahn SE, Andrikopoulos S, Verchere CB. Kahn SE, et al. Diabetes. 1999 Feb;48(2):241-53. doi: 10.2337/diabetes.48.2.241. Diabetes. 1999. PMID: 10334297 Review.
Optimum BMI cut points to screen asian americans for type 2 diabetes.
Araneta MR, Kanaya AM, Hsu WC, Chang HK, Grandinetti A, Boyko EJ, Hayashi T, Kahn SE, Leonetti DL, McNeely MJ, Onishi Y, Sato KK, Fujimoto WY. Araneta MR, et al. Diabetes Care. 2015 May;38(5):814-20. doi: 10.2337/dc14-2071. Epub 2015 Feb 9. Diabetes Care. 2015. PMID: 25665815 Free PMC article.
Proteoglycans synthesized and secreted by pancreatic islet beta-cells bind amylin.
Potter-Perigo S, Hull RL, Tsoi C, Braun KR, Andrikopoulos S, Teague J, Bruce Verchere C, Kahn SE, Wight TN. Potter-Perigo S, et al. Arch Biochem Biophys. 2003 May 15;413(2):182-90. doi: 10.1016/s0003-9861(03)00116-4. Arch Biochem Biophys. 2003. PMID: 12729615
The effect of apolipoprotein E deficiency on islet amyloid deposition in human islet amyloid polypeptide transgenic mice.
Vidal J, Verchere CB, Andrikopoulos S, Wang F, Hull RL, Cnop M, Olin KL, LeBoeuf RC, O'Brien KD, Chait A, Kahn SE. Vidal J, et al. Diabetologia. 2003 Jan;46(1):71-9. doi: 10.1007/s00125-002-0984-5. Epub 2003 Jan 9. Diabetologia. 2003. PMID: 12637985
Genetic background determines the extent of islet amyloid formation in human islet amyloid polypeptide transgenic mice.
Hull RL, Watts MR, Kodama K, Shen ZP, Utzschneider KM, Carr DB, Vidal J, Kahn SE. Hull RL, et al. Am J Physiol Endocrinol Metab. 2005 Oct;289(4):E703-9. doi: 10.1152/ajpendo.00471.2004. Epub 2005 May 17. Am J Physiol Endocrinol Metab. 2005. PMID: 15899941 Free article.
Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid.
Hull RL, Andrikopoulos S, Verchere CB, Vidal J, Wang F, Cnop M, Prigeon RL, Kahn SE. Hull RL, et al. Diabetes. 2003 Feb;52(2):372-9. doi: 10.2337/diabetes.52.2.372. Diabetes. 2003. PMID: 12540610 Free article.
Insulin and amylin release are both diminished in first-degree relatives of subjects with type 2 diabetes.
Knowles NG, Landchild MA, Fujimoto WY, Kahn SE. Knowles NG, et al. Diabetes Care. 2002 Feb;25(2):292-7. doi: 10.2337/diacare.25.2.292. Diabetes Care. 2002. PMID: 11815498
18 results
Jump to page